🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open, multi-cohort, multi-center, exploratory and phase II clini...
Status
Unknown
Location
Jiangsu Cancer Hospital
Start Date
2021-12-01
Trial ID
NCT05262335
This is a prospective, multicentre, cohort study. For cohort 1(CGA cohort),...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-11
Trial ID
NCT06665087
The purpose of this study is to determine that panitumumab will have clinic...
Status
Completed
Location
Multiple Locations
Start Date
2004-03
Trial ID
NCT00083616
Treatments Being Tested
This 2 arm study will assess the efficacy and safety of intermittent oral X...
Status
Completed
Location
Multiple Locations
Start Date
2003-07
Trial ID
NCT00069108
Treatments Being Tested
Chemotherapy is an important therapeutic method for patients with advanced ...
Status
Unknown
Location
Jinling Hospital
Start Date
2015-01-04
Trial ID
NCT02338518
Treatments Being Tested
This is a phase II, multi-arm, Bayesian adaptive platform trial designed to...
Status
Recruiting
Location
Zhongshan Hospital, Fudan University
Start Date
2026-01-19
Trial ID
NCT07328009
To explore the safety and efficacy of NALIRIFOX plus targeted therapy versu...
Status
Recruiting
Location
Shanghai Zhongshan Hospital
Start Date
2025-07-01
Trial ID
NCT07309289
Treatments Being Tested
The objective is to investigate the efficacy and safety of two-weekly alter...
Status
Unknown
Location
Jiangsu Cancer Institute & Hospital
Start Date
2019-09-01
Trial ID
NCT04324476
Treatments Being Tested
The primary objective of this study is to determine whether systemic chemot...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2014-03
Trial ID
NCT02102789
To evaluate the efficacy and safety of HAIC combined with Durvalumab, Treme...
Status
Unknown
Location
Tianjin Cancer Hospital Airport Hospital
Start Date
2023-06-20
Trial ID
NCT05864755
Treatments Being Tested